Haemonetics Raises FY2027 Sales Guidance from $1.401B-$1.441B to $1.441B-$1.481B vs $1.418B Est
Benzinga Newsdesk 8 hours ago
NewsGuidance
Haemonetics (NYSE:HAE) raises FY2027 sales outlook from $1.401 billion-$1.441 billion to $1.441 billion-$1.481 billion vs $1.418 billion estimate.
Haemonetics (NYSE:HAE) raises FY2027 sales outlook from $1.401 billion-$1.441 billion to $1.441 billion-$1.481 billion vs $1.418 billion estimate.